Browsed by
Author: Daniel Pham

Science policy weekly roundup: September 21, 2018 ?>

Science policy weekly roundup: September 21, 2018

The ASBMB PAAC responds to NIH statement addressing sexual harassment in science The ASBMB PAAC released a statement in response to the NIH’s latest statement regarding sexual harassment in science. The PAAC urged the NIH to define how the agency will respond to violations of sexual harassment policies at NIH-funded institutions. Read the statement here.   U.S. Senate passes spending bill that increases NIH budget by $2 billion The Senate voted 93-7 on Sept. 18 to pass an $854 billion…

Read More Read More

Science policy weekly roundup: Sept. 7, 2018 ?>

Science policy weekly roundup: Sept. 7, 2018

FDA says Trump administration’s limits on foreign hires hinders recruiting power According to Melanie Keller, acting associate commissioner for scientific and clinical recruitment at the Food and Drug Administration, limits on foreign hires placed by the Trump administration have hampered the regulatory agency’s ability to attract top scientists. The policy, implemented in August 2017, requires the FDA to hire candidates who have lived in the U.S. for three of the past five years. Read more here.   Trump walks back…

Read More Read More

Science policy weekly roundup: August 31, 2018 ?>

Science policy weekly roundup: August 31, 2018

Senate committee holds hearing on nomination of Kelvin Droegemeier to head OSTP Science Policy Analyst André Porter discusses last week’s U.S. Senate committee hearing to nominate Kelvin Droegemeier to lead the Office of Science and Technology Policy. Several senators asked the nominee about how he would ensure that scientific evidence would be taken seriously by the administration. Droegemeier, a meteorologist, also side-stepped questions regarding whether humans were responsible for climate change. Read more here.   Elizabeth Warren raises concern about…

Read More Read More

Sen. Warren, D-Mass., raises concern about private funding to the NIH ?>

Sen. Warren, D-Mass., raises concern about private funding to the NIH

When National Institutes of Health Director Francis S. Collins testified before a U.S. Senate committee last week about prioritizing cures, most senators asked him about how research is progressing on specific diseases. U.S. Sen. Elizabeth Warren, a Democrat from Massachusetts, however, raised questions about the role of the Foundation for the NIH in soliciting private dollars to fund NIH studies. Established by Congress in 1990, the FNIH is a nonprofit that solicits donations from companies and other organizations to help…

Read More Read More

Science policy weekly roundup: August 24, 2018 ?>

Science policy weekly roundup: August 24, 2018

  What do you think about NIH efforts to support next generation of researchers? The National Institutes of Health is proposing recommendations to support the next generation of researchers, and we at the American Society for Biochemistry and Molecular Biology want to know what you think. We will collect your feedback and send it to the NIH. Submit your opinion and view a timeline of the ASBMB’s involvement here. U.S. Senate passes NIH appropriations bill In an 85-7 vote on…

Read More Read More

Science policy weekly roundup: August 17, 2018 ?>

Science policy weekly roundup: August 17, 2018

  Congress struggles to pass funding bills as deadline looms Back from its abridged recess, the U.S. Senate is back to work on a set of bills to fund the majority of the federal government. While senators hope to keep their funding bills free of polarizing measures, several provisions in the House bill are being opposed by House Democrats. Additionally, President Donald Trump has threatened to veto any budget that excludes significant funding for a southern border wall. These significant…

Read More Read More

Episode 12 of Pipettes and Politics is available ?>

Episode 12 of Pipettes and Politics is available

Episode 12 of the American Society of Biochemistry and Molecular Biology’s science policy podcast, “Pipettes and Politics,” is now available.   In this episode, ASBMB Public Affairs Director Benjamin Corb talks with Rush Holt, chief executive officer at the American Association for the Advancement of Science, about scientists running for office. Holt describes his time as a former congressional representative and how his scientific training affected his experience in Congress. Corb also provides an update on the recent appointment of Kelvin…

Read More Read More

Science policy weekly roundup: August 10, 2018 ?>

Science policy weekly roundup: August 10, 2018

Members of Congress urge NIH to take action to stop sexual harassment in science U.S. Sen. Patty Murray, D-Wash., and U.S. Rep. Rosa DeLauro, D-Conn., sent a letter Monday to the National Institutes of Health requesting a briefing about how the agency is addressing sexual harassment in science. The lawmakers’ letter asked NIH officials to provide information about its sexual harassment policy, relevant working groups or task forces, and the number of harassment settlements that occurred in NIH-supported facilities. Read the…

Read More Read More

Science policy weekly roundup: August 3, 2018 ?>

Science policy weekly roundup: August 3, 2018

ASBMB supports Trump’s nominee to lead White House science advisory group The American Society for Biochemistry and Molecular Biology applauds the nomination of Kelvin Droegemeier to lead the White House Office of Science and Technology Policy. The OSTP has lacked a director for 19 months. President Donald Trump’s nominee is a respected meteorologist with extensive leadership experience at science organizations including the National Science Foundation. Read more here.   Trump mulls shutdown as Congress looks to fund government Congressional leaders…

Read More Read More

The ASBMB supports Trump nominee to lead Office of Science and Technology Policy ?>

The ASBMB supports Trump nominee to lead Office of Science and Technology Policy

The American Society for Biochemistry and Molecular Biology supports U.S. President Donald Trump’s nomination of Kelvin Droegemeier to be the next director of the White House Office of Science and Technology Policy. If confirmed by the U.S. Senate, Droegemeier, a meteorologist specializing in extreme weather, would be the first person to lead the office since Trump’s inauguration. Other OSTP positions also have remained vacant since Trump took office more than 19 months ago. The OSTP was reportedly staffed by only 35 employees…

Read More Read More